{"id":"W2083008217","doi":"10.1016/j.vaccine.2008.02.072","title":"EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone","year":2008,"lang":"en","type":"article","venue":"Vaccine","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":102,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sanofi (Canada)","funders":"Centre Hospitalier Universitaire Vaudois; Imperial College London; National Institute for Health and Care Research","keywords":"ELISPOT; Immunogenicity; Medicine; Regimen; Adverse effect; Immunology; Internal medicine; Asymptomatic; Gastroenterology; Virology; Surgery; Pharmacology; Immune system; T cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001639187,0.001677098,0.001615921,0.0004627277,0.0003228668,0.001154087,0.0009126671,0.001989186,0.005736782],"category_scores_gemma":[0.001017637,0.0004609006,0.001016309,0.0003264183,0.000990768,0.001090704,0.0003289196,0.003354188,0.001175993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006112238,"about_ca_system_score_gemma":0.001184989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005004811,"about_ca_topic_score_gemma":0.0006326863,"domain_scores_codex":[0.9995331,0.0002278501,0.00001721239,0.00007640959,0.00003940388,0.0001061374],"domain_scores_gemma":[0.9994513,0.0001706843,0.00007499362,0.0000415994,0.00002582633,0.0002356193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9003841,0.02164259,0.001305364,0.0004063261,0.0005020378,0.00008842903,0.00008224251,0.001168544,0.02170372,0.0005980224,0.002314927,0.04980377],"study_design_scores_gemma":[0.5572391,0.4295071,0.002734633,0.00004449043,0.0002337142,0.0002598144,0.00004404492,0.001171847,0.006324509,0.0004807598,0.001933872,0.00002623404],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903347,0.002529536,0.0009301517,0.0004540419,0.0003295104,0.001083161,0.00117133,0.0002032534,0.00296433],"genre_scores_gemma":[0.9871524,0.001252216,0.001815321,0.0009159766,0.0003595239,0.001179365,0.002524291,0.00005905127,0.004741782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005736782,"threshold_uncertainty_score":0.01919138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02434066180072997,"score_gpt":0.2942020633388696,"score_spread":0.2698614015381396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}